News | Clinical Decision Support | April 19, 2017

Siemens Healthineers Supports Population Health Management With Planned Acquisition of Medicalis

Acquisition will expand Siemens’ capabilities for clinical decision support, imaging workflow and referral management

Siemens Healthineers Supports Population Health Management With Planned Acquisition of Medicalis

April 19, 2017 — Siemens Healthineers plans to expand its Population Health Management (PHM) portfolio with the acquisition of Medicalis Corp. based in San Francisco and Kitchener, Ontario. Medicalis is a leading provider of clinical decision support (CDS) solutions at the point of order entry, imaging workflow (IW) management and referral management (RM).

By incorporating these offerings into its PHM portfolio, Siemens Healthineers will enable healthcare providers to effectively bridge between PHM at the health system level and at the departmental level. 

The newly-acquired Population Health Management portfolio will extend the Siemens Healthineers strategy for Value-Based Healthcare across the health system enterprise and hospital departmental levels:

  • Clinical decision support (CDS) provides the mechanism, as defined under the Protecting Access to Medicare Act of 2014 (PAMA), to check appropriateness of imaging orders and enables healthcare providers to define and evolve their standard of care, according to their appropriate use criteria (AUC), based on evidence and best practice. Today, 20–30 percent of high-tech imaging procedures fail to provide information that improves patient welfare and, therefore, may represent, at least in part, unnecessary imaging services;
  • Imaging workflow orchestrates the interpreting physician desktop, streamlining workflow, and standardization of diagnostic pathways for high-impact disease states. It ensures the right specialist, the right tools, a timely read and prevention of care gaps; and
  • Referral management helps to avoid breaks in care by providing simple appointment scheduling tools, which help a patient schedule examinations in their network. This avoids leakage of patient information to another health system, which breaks communication and causes lost revenue.

In the short term, the solutions developed by Medicalis are expected to address the immediate need for consolidating providers to orchestrate and standardize their imaging workflow and to achieve compliance with PAMA, expected to become effective on Jan. 1, 2018, which mandates consultation of appropriateness CDS at the point of order for certain advanced imaging tests. Siemens Healthineers believes these solutions will enable providers to achieve PAMA compliance while retaining control over the content, allowing them to move beyond simple compliance toward truly establishing an evolving standard of care based on evidence and direct health system experience.

The solutions developed by Medicalis allow networks of hospitals (health systems/integrated delivery networks) to improve physician productivity, manage patient referrals, and scheduling to enhance the relationship with the patient and ensure clinically appropriate imaging and tests to reduce inappropriate utilization. 

The acquisition agreement was signed in April 2017.  Terms of the transaction are not disclosed. The closing of the acquisition is subject to customary closing conditions.

For more information: www.usa.healthcare.siemens.com

Related Content

Qure.ai, a leading healthcare AI startup
News | Artificial Intelligence | February 27, 2020
February 27, 2020 — Qure.ai, a leading healthcare AI startup has ann
An illustration of the novel coronavirus (COVID-19) from the CDC. #coronavirus #COVID19 #COVID-2019 #2019nCoV

An illustration of the novel coronavirus (COVID-19) from the CDC.

Feature | Coronavirus (COVID-19) | February 25, 2020 | Dave Fornell, Editor
Sponsored Content | Videos | Artificial Intelligence | February 21, 2020
In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial intel
Altamont’s zero-footprint solution, CaptureWare, allows Mach7’s Enterprise Imaging Platform (EIP) to ingest more DICOM and/or non-DICOM data from various sources in a facility
News | PACS | February 20, 2020
February 20, 2020 — Mach7 announced its partnership with Altamont
Sponsored Content | Videos | Enterprise Imaging | February 19, 2020
Bill Lacy, vice president, Medical Informatics at FUJIFILM Medic...
The Candelis ImageGrid Plus PACS Server is an ultra-high-performance platform that can support high volume healthcare environments of 1,000 plus modalities
News | PACS | February 12, 2020
February 12, 2020 — The Candelis ImageGrid Plus...
An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019.

An example of artificial intelligence (AI) being developed by Hitachi to automatically review and identify nodules on lung CT scans. This is part of a suite of AI apps Hitachi is developing. This example was being shown as a work in progress at RSNA 2019. Photo by Dave Fornell.

Feature | Artificial Intelligence | February 07, 2020 | Sanjay Parekh, Ph.D. 
February 7, 2020 – At the 2019 Radiological Society...
Qynapse, a medical technology company, announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its QyScore software
News | Information Technology | February 04, 2020
February 4, 2020 — Qynapse, a medical technology company, anno